These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30540681)

  • 1. Diagnostic and Prognostic Impact of Neutrophil-to-Lymphocyte Ratio for Intraductal Papillary Mucinous Neoplasms of the Pancreas With High-Grade Dysplasia and Associated Invasive Carcinoma.
    Hata T; Mizuma M; Motoi F; Ishida M; Morikawa T; Takadate T; Nakagawa K; Hayashi H; Kanno A; Masamune A; Kamei T; Furukawa T; Naitoh T; Unno M
    Pancreas; 2019 Jan; 48(1):99-106. PubMed ID: 30540681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnostic efficacy for predicting intraductal papillary mucinous neoplasms of the pancreas with high grade dysplasia or invasive carcinoma based on the surgery indications in different guidelines].
    Li B; Guo SW; Shi XH; Shen S; Zhang GX; Gao SZ; Pan YQ; Xu XF; Jin G
    Zhonghua Wai Ke Za Zhi; 2021 May; 59(5):359-365. PubMed ID: 33915626
    [No Abstract]   [Full Text] [Related]  

  • 3. An integrated analysis of host- and tumor-derived markers for predicting high-grade dysplasia and associated invasive carcinoma of intraductal papillary mucinous neoplasms of the pancreas.
    Hata T; Mizuma M; Motoi F; Ishida M; Morikawa T; Nakagawa K; Hayashi H; Kanno A; Masamune A; Kamei T; Naitoh T; Furukawa T; Unno M
    Surg Today; 2020 Sep; 50(9):1039-1048. PubMed ID: 32124086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil-to-lymphocyte Ratio is a Predictive Marker for Invasive Malignancy in Intraductal Papillary Mucinous Neoplasms of the Pancreas.
    Gemenetzis G; Bagante F; Griffin JF; Rezaee N; Javed AA; Manos LL; Lennon AM; Wood LD; Hruban RH; Zheng L; Zaheer A; Fishman EK; Ahuja N; Cameron JL; Weiss MJ; He J; Wolfgang CL
    Ann Surg; 2017 Aug; 266(2):339-345. PubMed ID: 27631774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil-to-Lymphocyte Ratio as a Predictor of Invasive Carcinoma in Patients With Intraductal Papillary Mucinous Neoplasms of the Pancreas.
    McIntyre CA; Pulvirenti A; Lawrence SA; Seier K; Gonen M; Balachandran VP; Kingham TP; DʼAngelica MI; Drebin JA; Jarnagin WR; Allen PJ
    Pancreas; 2019 Jul; 48(6):832-836. PubMed ID: 31210665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Anti-p53 Antibody Can Serve as a Predictive Marker for Histological Grade of Intraductal Papillary Mucinous Neoplasms of the Pancreas.
    Hata T; Mizuma M; Motoi F; Iseki M; Omori Y; Hayashi H; Nakagawa K; Morikawa T; Kamei T; Naitoh T; Furukawa T; Unno M
    Pancreas; 2020 Jul; 49(6):768-773. PubMed ID: 32541631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic Fluid Interleukin-1β Complements Prostaglandin E2 and Serum Carbohydrate Antigen 19-9 in Prediction of Intraductal Papillary Mucinous Neoplasm Dysplasia.
    Simpson RE; Yip-Schneider MT; Flick KF; Wu H; Colgate CL; Schmidt CM
    Pancreas; 2019 Sep; 48(8):1026-1031. PubMed ID: 31404023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical implication of serum carcinoembryonic antigen and carbohydrate antigen 19-9 for the prediction of malignancy in intraductal papillary mucinous neoplasm of pancreas.
    Kim JR; Jang JY; Kang MJ; Park T; Lee SY; Jung W; Chang J; Shin Y; Han Y; Kim SW
    J Hepatobiliary Pancreat Sci; 2015 Sep; 22(9):699-707. PubMed ID: 26178866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil-to-lymphocyte ratio and mural nodule height as predictive factors for malignant intraductal papillary mucinous neoplasms.
    Watanabe Y; Niina Y; Nishihara K; Okayama T; Tamiya S; Nakano T
    Acta Chir Belg; 2018 Aug; 118(4):239-245. PubMed ID: 29334845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor II messenger RNA-binding protein-3 is a valuable diagnostic and prognostic marker of intraductal papillary mucinous neoplasm.
    Morimatsu K; Aishima S; Yamamoto H; Hayashi A; Nakata K; Oda Y; Shindo K; Fujino M; Tanaka M; Oda Y
    Hum Pathol; 2013 Sep; 44(9):1714-21. PubMed ID: 23597774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.
    Masuda A; Arisaka Y; Hara S; Matsumoto I; Takenaka M; Sakai A; Shiomi H; Matsuki N; Sugimoto M; Fujita T; Hayakumo T; Ku Y; Ogino S; Azuma T; Kutsumi H
    Pancreatology; 2013; 13(6):583-8. PubMed ID: 24280573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of 18-FDG PET/CT in Detecting Malignancy in Intraductal Papillary Mucinous Neoplasms of the Pancreas.
    Yamashita YI; Okabe H; Hayashi H; Imai K; Nakagawa S; Nakao Y; Yusa T; Itoyama R; Yama T; Umesaki N; Arima K; Miyata T; Chikamoto A; Baba H
    Anticancer Res; 2019 May; 39(5):2493-2499. PubMed ID: 31092444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Neutrophil-to-Lymphocyte Ratio Predicts Malignant Potential in Intraductal Papillary Mucinous Neoplasms.
    Arima K; Okabe H; Hashimoto D; Chikamoto A; Kuroki H; Taki K; Kaida T; Higashi T; Nitta H; Komohara Y; Beppu T; Takeya M; Baba H
    J Gastrointest Surg; 2015 Dec; 19(12):2171-7. PubMed ID: 26443528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil-to-lymphocyte Ratio as a Predictor of Malignancy of Intraductal Papillary Mucinous Neoplasms.
    Sugimachi K; Mano Y; Matsumoto Y; Nakanoko T; Uehara H; Nakashima Y; Sugiyama M; Ota M; Morita M; Toh Y
    Anticancer Res; 2021 Mar; 41(3):1663-1669. PubMed ID: 33788763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diagnostic role of the neutrophil-to-lymphocyte ratio in predicting pancreatic ductal adenocarcinoma in patients with pancreatic diseases.
    Arima K; Okabe H; Hashimoto D; Chikamoto A; Tsuji A; Yamamura K; Kitano Y; Inoue R; Kaida T; Higashi T; Taki K; Imai K; Komohara Y; Beppu T; Takeya M; Baba H
    Int J Clin Oncol; 2016 Oct; 21(5):940-945. PubMed ID: 27023215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-institutional Validation Study of Pancreatic Cyst Fluid Protein Analysis for Prediction of High-risk Intraductal Papillary Mucinous Neoplasms of the Pancreas.
    Al Efishat MA; Attiyeh MA; Eaton AA; Gönen M; Prosser D; Lokshin AE; Castillo CF; Lillemoe KD; Ferrone CR; Pergolini I; Mino-Kenudson M; Rezaee N; Dal Molin M; Weiss MJ; Cameron JL; Hruban RH; D'Angelica MI; Kingham TP; DeMatteo RP; Jarnagin WR; Wolfgang CL; Allen PJ
    Ann Surg; 2018 Aug; 268(2):340-347. PubMed ID: 28700444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The value of preoperative CA19-9 combined with platelet-to-lymphocyte ratio in predicting invasive malignancy in intraductal papillary mucinous neoplasms].
    Li JA; Han X; Fang Y; Zhang L; Lou WH; Xu XF; Wu WC; Kuang TT; Wang DS; Rong YF
    Zhonghua Wai Ke Za Zhi; 2019 Mar; 57(3):170-175. PubMed ID: 30861644
    [No Abstract]   [Full Text] [Related]  

  • 18. Neutrophil to Lymphocyte Ratio is a Predictive Factor of Malignant Potential for Intraductal Papillary Mucinous Neoplasms of the pancreas.
    Ohno R; Kawamoto R; Kanamoto M; Watanabe J; Fujii M; Ohtani H; Harada M; Kumagi T; Kawasaki H
    Biomark Insights; 2019; 14():1177271919851505. PubMed ID: 31210727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraductal papillary mucinous neoplasm of the pancreas: cytologic features predict histologic grade.
    Michaels PJ; Brachtel EF; Bounds BC; Brugge WR; Pitman MB
    Cancer; 2006 Jun; 108(3):163-73. PubMed ID: 16550572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic study of the MIB-1 labeling index (Ki67) and postoperative prognosis for intraductal papillary mucinous neoplasms and ordinary ductal adenocarcinoma.
    Takeshita A; Kimura W; Hirai I; Takasu N; Moriya T; Tezuka K; Watanabe T
    Pancreas; 2012 Jan; 41(1):114-20. PubMed ID: 22143341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.